Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma

International Journal of Cancer

Volumn 95, Issue 1, 2001, Pages 44-50

  Yoshizaki, Tomokazu ^a   Maruyama, Yumiko ^a   Sato, Hiroshi ^a   Furukawa, Mitsuru ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Head and neck cancer; MMP2; MT1 MMP; Prognosis; TIMP2; Tongue cancer

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TONGUE CARCINOMA; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ENZYME ACTIVATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TONGUE NEOPLASMS;

EID: 0035915805     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010120)95:1<44::AID-IJC1008>3.0.CO;2-M     Document Type: Article

References (27)

1. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
2. The matrix-degrading metalloproteinases
3. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma
4. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas
5. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node
6. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma
7. A matrix metalloproteinase expressed on the surface of invasive tumor cells
8. Membrane type-matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2
9. Mechanism of cell surface activation of 72kDa type IV collagenase
10. Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer
11. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer
12. Prognostic value of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer
13. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells
14. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence
15. Recent advances in automated immunocytochemistry
16. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase
17. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1
18. Activity of type IV collagenases in benign and malignant breast disease
19. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas
20. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-I-matrix metalloproteinase (MT1-MMP)
21. Gelatinase A (MMP-2) and its mRNA detected in both neoplastic and stromal cells of tumors with different invasive and metastatic properties
22. Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: Quantificative and morphological analyses
23. MT-MMP expression and localisation in human lung and breast cancers
24. Molecular regulation of cellular invasion-role of gelatinase A and TIMP-2
25. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors